NO975700L - N-heteroaryl-pyridinsulfonamid-derivater og deres anvendelse som endotelin-antagonister - Google Patents

N-heteroaryl-pyridinsulfonamid-derivater og deres anvendelse som endotelin-antagonister

Info

Publication number: NO975700L
Authority: NO; Norway
Prior art keywords: heteroaryl; sulfonamide derivatives; endothelin antagonists; pyridine sulfonamide; pyridine
Prior art date: 1995-06-07

Application number

NO975700A

Other languages

English (en)

Other versions

NO314503B1 (no

NO975700D0 (no

Inventor

Robert Hugh Bradbury

Roger John Butlin

Roger James

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1997-12-05

Publication date

1997-12-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26307176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975700(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-06-07 Priority claimed from GBGB9511507.7A external-priority patent/GB9511507D0/en

1995-09-27 Priority claimed from GBGB9519666.3A external-priority patent/GB9519666D0/en

1997-12-05 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

1997-12-05 Publication of NO975700D0 publication Critical patent/NO975700D0/no

1997-12-05 Publication of NO975700L publication Critical patent/NO975700L/no

2003-03-31 Publication of NO314503B1 publication Critical patent/NO314503B1/no

Links

102000002045 Endothelin Human genes 0.000 title 1
108050009340 Endothelin Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO19975700A 1995-06-07 1997-12-05 N-Heteroarylpyridinsulfonamidderivater, anvendelse og fremstilling derav samt farmasöytisk preparat NO314503B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9511507.7A GB9511507D0 (en)	1995-06-07	1995-06-07	Heterocyclic compounds
GBGB9519666.3A GB9519666D0 (en)	1995-09-27	1995-09-27	Heterocyclic derivatives
PCT/GB1996/001295 WO1996040681A1 (en)	1995-06-07	1996-06-03	N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists

Publications (3)

Publication Number	Publication Date
NO975700D0 NO975700D0 (no)	1997-12-05
NO975700L true NO975700L (no)	1997-12-05
NO314503B1 NO314503B1 (no)	2003-03-31

Family

ID=26307176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19975700A NO314503B1 (no)	1995-06-07	1997-12-05	N-Heteroarylpyridinsulfonamidderivater, anvendelse og fremstilling derav samt farmasöytisk preparat

Country Status (31)

Country	Link
US (3)	US5866568A (no)
EP (1)	EP0832082B1 (no)
JP (1)	JP3193058B2 (no)
KR (1)	KR100451523B1 (no)
CN (1)	CN1097051C (no)
AR (1)	AR003132A1 (no)
AT (1)	ATE209200T1 (no)
AU (1)	AU715041B2 (no)
BR (1)	BR9608611A (no)
CA (1)	CA2219742C (no)
CZ (1)	CZ289387B6 (no)
DE (1)	DE69617236T2 (no)
DK (1)	DK0832082T3 (no)
EG (1)	EG25227A (no)
ES (1)	ES2168487T3 (no)
GE (1)	GEP20053470B (no)
HR (1)	HRP960272B1 (no)
HU (1)	HUP9802300A3 (no)
IL (1)	IL122464A (no)
MX (1)	MX9709521A (no)
MY (1)	MY114926A (no)
NO (1)	NO314503B1 (no)
NZ (1)	NZ308619A (no)
PL (1)	PL187897B1 (no)
PT (1)	PT832082E (no)
RU (1)	RU2172738C2 (no)
SK (1)	SK282338B6 (no)
TR (1)	TR199701502T1 (no)
TW (1)	TW340845B (no)
UA (1)	UA58494C2 (no)
WO (1)	WO1996040681A1 (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5962490A (en) *	1987-09-25	1999-10-05	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en)	1994-05-20	2002-04-23	Texas Biotechnology Corporation	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en)	1993-05-20	2003-09-02	Encysive Pharmaceuticals, Inc.	Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en)	1993-05-20	2003-04-01	Texas Biotechnology	Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en)	1993-05-20	2002-01-29	Texas Biotechnology Corp.	N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5612359A (en) *	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
US5760038A (en) *	1995-02-06	1998-06-02	Bristol-Myers Squibb Company	Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) *	1995-02-06	1998-07-14	Bristol-Myers Squibb Company	Substituted biphenyl sulfonamide endothelin antagonists
US5846990A (en) *	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) *	1995-10-11	1997-05-13	Bristol Myers Squibb Co	置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5977117A (en)	1996-01-05	1999-11-02	Texas Biotechnology Corporation	Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5856507A (en) *	1997-01-21	1999-01-05	Bristol-Myers Squibb Co.	Methods for the preparation of biphenyl isoxazole sulfonamides
WO1997029747A1 (en)	1996-02-20	1997-08-21	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
US5939446A (en) *	1996-04-09	1999-08-17	Bristol-Myers Squibb Co.	Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en)	1996-04-15	1998-09-08	Texas Biotechnology Corporation	Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
GB9614804D0 (en) *	1996-07-15	1996-09-04	Chiroscience Ltd	Resolution process
WO1998033781A1 (en) *	1997-01-30	1998-08-06	Bristol-Myers Squibb Company	Method for preventing or treating low renin hypertension by administering an endothelin antagonist
TW536540B (en) *	1997-01-30	2003-06-11	Bristol Myers Squibb Co	Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
GB9704762D0 (en) *	1997-03-07	1997-04-23	Zeneca Ltd	Chemical process
SG100767A1 (en)	1997-04-28	2003-12-26	Texas Biotechnology Corp	Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en)	1997-04-28	1998-07-21	Texas Biotechnology Corporation	Process of preparing alkali metal salys of hydrophobic sulfonamides
MXPA01009362A (es)	1999-03-19	2002-06-04	Squibb Bristol Myers Co	Metodos para la preparacion de bifenil isoxazol sulfonamidas.
US6448239B1 (en) *	1999-06-03	2002-09-10	Trustees Of Princeton University	Peroxynitrite decomposition catalysts and methods of use thereof
MXPA02006461A (es)	1999-12-31	2003-09-05	Texas Biotechnology Corp	Sulfonamidas y derivados de las mismas que modulan la actividad de endotelina.
US6639082B2 (en)	2000-10-17	2003-10-28	Bristol-Myers Squibb Company	Methods for the preparation of biphenyl isoxazole sulfonamides
US7041280B2 (en) *	2001-06-29	2006-05-09	Genzyme Corporation	Aryl boronate functionalized polymers for treating obesity
US6858592B2 (en)	2001-06-29	2005-02-22	Genzyme Corporation	Aryl boronic acids for treating obesity
GB0219660D0 (en) *	2002-08-23	2002-10-02	Astrazeneca Ab	Therapeutic use
GB0223854D0 (en) *	2002-10-12	2002-11-20	Astrazeneca Ab	Therapeutic treatment
RU2234331C1 (ru) *	2002-12-30	2004-08-20	Смирнов Алексей Владимирович	Лекарственное средство
US7169805B2 (en) *	2003-05-28	2007-01-30	Nicox S.A.	Captopril derivatives
GB0320806D0 (en) *	2003-09-05	2003-10-08	Astrazeneca Ab	Therapeutic treatment
GB0403744D0 (en) *	2004-02-20	2004-03-24	Astrazeneca Ab	Chemical process
KR100839512B1 (ko) *	2004-07-02	2008-06-19	주식회사 코오롱	설파제를 디아조화체로 하는 산성 항균 염료 및 그를이용한 항균 섬유
RU2399614C2 (ru) *	2004-09-21	2010-09-20	Астеллас Фарма Инк.	Аминоспиртовые производные
EP1824861A2 (en)	2004-11-12	2007-08-29	Trustees of the Tufts College	Lipase inhibitors
US20070054325A1 (en) *	2005-04-14	2007-03-08	Reglia	Materials and methods for screening modulators of neural regeneration
GB0514743D0 (en) *	2005-07-19	2005-08-24	Astrazeneca Ab	Salt
RU2492185C2 (ru)	2005-12-13	2013-09-10	Астразенека Аб	Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование
MX2008011227A (es) *	2006-03-03	2009-02-10	Torrent Pharmaceuticals Ltd	Receptores antagonistas de accion nueva y doble en los receptores at1 y eta.
JP2009533420A (ja) *	2006-04-13	2009-09-17	アクテリオンファーマシューティカルズリミテッド	早期特発性肺線維症の治療
DE602007012299D1 (de) *	2006-09-21	2011-03-10	Piramal Live Science Ltd	Pyridinderivate für die behandlung von stoffwechselstörungen, die mit insulinresistenz oder hyperglykämie in zusammenhang stehen
CL2008000191A1 (es)	2007-01-25	2008-08-22	Astrazeneca Ab	Compuestos derivados de 4-amino-cinnotina-3-carboxamida; inhibidores de csf-1r quinasa; su proceso de preparacion; y su uso para tratar el cancer.
BRPI0811020A2 (pt)	2007-05-03	2015-07-21	Intermune Inc	Composto, composição farmacêutica e métodos de inibição da atividade da protease ns3/ns4, de tratamento da fibrose hepática, de intensificação da função hepática em indivíduo com infecção do vírus da hepatite c e métodos de síntese de compostos, de administração de inibidor da infecção do vírus da hepatite c (hcv) e de distribuição de forma de dosagem oral.
PT2209501E (pt)	2007-10-12	2012-02-03	Astrazeneca Ab	Composição de zibotentan contendo manitol e celulose microcristalina
JO3465B1 (ar)	2008-06-19	2020-07-05	Takeda Pharmaceuticals Co	مركب متغاير الحلقه واستخدامه
CA2751695C (en) *	2009-02-06	2017-11-28	Nippon Shinyaku Co., Ltd.	Aminopyrazine derivatives and medicines
CN102491973A (zh) *	2011-12-15	2012-06-13	南京友杰医药科技有限公司	Zd-4054的合成方法
US12233061B2 (en)	2019-02-12	2025-02-25	The University Court Of The University Of Glasgow	Microvascular angina
US20230227477A1 (en) *	2020-06-25	2023-07-20	Wake Forest University Health Sciences	Compounds for sensing reactive oxygen species and methods for using the same
IL299568A (en)	2020-07-10	2023-02-01	Astrazeneca Ab	A combination of zibutantan and dapagliflozin for the treatment of chronic kidney disease
JP7531947B2 (ja) *	2021-06-22	2024-08-13	株式会社アークメディスン	化合物、エンドセリンａ受容体拮抗剤及び医薬組成物
AR130179A1 (es)	2022-08-12	2024-11-13	Astrazeneca Ab	Terapias combinadas para el tratamiento de la cirrosis con hipertensión portal
CN120641101A (zh)	2023-02-08	2025-09-12	阿斯利康(瑞典)有限公司	用于治疗高蛋白尿慢性肾病的齐泊腾坦和达格列净的组合
WO2025133907A1 (en)	2023-12-18	2025-06-26	Astrazeneca Ab	Combination of zibotentan and dapagliflozin for the treatment of microvascular angina
WO2025163559A1 (en)	2024-02-01	2025-08-07	Astrazeneca Ab	Combination of zibotentan and dapagliflozin for use for the treatment of hypertension

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0655708B2 (ja) *	1985-05-13	1994-07-27	三井東圧化学株式会社	スルホンアミド系化合物及び農業用殺菌剤
RU2043718C1 (ru) *	1986-01-31	1995-09-20	Исихара Сангио Кайся Лтд.	Способ борьбы с нежелательным ростом растений
US5594021A (en) *	1993-05-20	1997-01-14	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US5591761A (en) *	1993-05-20	1997-01-07	Texas Biotechnology Corporation	Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5571821A (en) *	1993-05-20	1996-11-05	Texas Biotechnology Corporation	Sulfonamides and derivatives thereof that modulate the activity of endothelin
US5464853A (en) *	1993-05-20	1995-11-07	Immunopharmaceutics, Inc.	N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US5514691A (en) *	1993-05-20	1996-05-07	Immunopharmaceutics, Inc.	N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin
JPH04503672A (ja) *	1989-02-27	1992-07-02	イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー	放射線増感剤としての新規なナフタレンスルホンアミド
TW270116B (no) *	1991-04-25	1996-02-11	Hoffmann La Roche
WO1992020746A1 (en) *	1991-05-14	1992-11-26	Hybritech, Incorporated	Polymeric compositions having bound antibodies
RU2086544C1 (ru) *	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
TW224462B (no) *	1992-02-24	1994-06-01	Squibb & Sons Inc
EP0647236A1 (en) *	1992-04-22	1995-04-12	Warner-Lambert Company	Endothelin antagonists ii
NZ247440A (en) *	1992-05-06	1995-04-27	Squibb & Sons Inc	Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
AU4679793A (en) *	1992-07-17	1994-02-14	Smithkline Beecham Corporation	Endothelin receptor antagonists
TW287160B (no) *	1992-12-10	1996-10-01	Hoffmann La Roche
EP0626174A3 (en) *	1993-04-21	1996-01-03	Takeda Chemical Industries Ltd	Method and composition for the prophylaxis and / or treatment of underactive organs.
US5965732A (en) *	1993-08-30	1999-10-12	Bristol-Myers Squibb Co.	Sulfonamide endothelin antagonists
GB9504854D0 (en) *	1994-03-31	1995-04-26	Zeneca Ltd	Nitrogen derivatives
GB9409618D0 (en) *	1994-05-13	1994-07-06	Zeneca Ltd	Pyridine derivatives
DE4426346A1 (de) *	1994-07-25	1996-02-01	Basf Ag	Herbizide Pyrazinderivate
US5612359A (en) *	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
GB2295616A (en) *	1994-12-01	1996-06-05	Zeneca Ltd	N-Diazine-benzenesulphonamide derivatives as endothelin receptor antagonists
KR100359396B1 (ko) *	1995-04-04	2003-03-15	텍사스 바이오테크놀로지 코포레이션	엔도텔린의활성을조절하는티에닐-,푸릴-및피롤릴설폰아미드및이의유도체

1996
- 1996-03-06 UA UA98010043A patent/UA58494C2/uk unknown
- 1996-06-03 DE DE69617236T patent/DE69617236T2/de not_active Expired - Lifetime
- 1996-06-03 KR KR1019970708807A patent/KR100451523B1/ko not_active Expired - Fee Related
- 1996-06-03 RU RU98100054/04A patent/RU2172738C2/ru not_active IP Right Cessation
- 1996-06-03 CN CN96196149A patent/CN1097051C/zh not_active Expired - Fee Related
- 1996-06-03 HU HU9802300A patent/HUP9802300A3/hu unknown
- 1996-06-03 WO PCT/GB1996/001295 patent/WO1996040681A1/en not_active Ceased
- 1996-06-03 JP JP50020997A patent/JP3193058B2/ja not_active Expired - Fee Related
- 1996-06-03 TR TR97/01502T patent/TR199701502T1/xx unknown
- 1996-06-03 EP EP96919941A patent/EP0832082B1/en not_active Expired - Lifetime
- 1996-06-03 BR BR9608611A patent/BR9608611A/pt not_active IP Right Cessation
- 1996-06-03 PT PT96919941T patent/PT832082E/pt unknown
- 1996-06-03 SK SK1680-97A patent/SK282338B6/sk not_active IP Right Cessation
- 1996-06-03 CA CA002219742A patent/CA2219742C/en not_active Expired - Fee Related
- 1996-06-03 DK DK96919941T patent/DK0832082T3/da active
- 1996-06-03 CZ CZ19973887A patent/CZ289387B6/cs not_active IP Right Cessation
- 1996-06-03 MX MX9709521A patent/MX9709521A/es unknown
- 1996-06-03 ES ES96919941T patent/ES2168487T3/es not_active Expired - Lifetime
- 1996-06-03 AT AT96919941T patent/ATE209200T1/de active
- 1996-06-03 PL PL96324660A patent/PL187897B1/pl not_active IP Right Cessation
- 1996-06-03 AU AU58403/96A patent/AU715041B2/en not_active Ceased
- 1996-06-03 NZ NZ308619A patent/NZ308619A/xx not_active IP Right Cessation
- 1996-06-03 IL IL12246496A patent/IL122464A/en not_active IP Right Cessation
- 1996-06-04 MY MYPI96002166A patent/MY114926A/en unknown
- 1996-06-04 TW TW085106632A patent/TW340845B/zh not_active IP Right Cessation
- 1996-06-04 AR ARP960102899A patent/AR003132A1/es active IP Right Grant
- 1996-06-04 US US08/658,969 patent/US5866568A/en not_active Expired - Lifetime
- 1996-06-06 HR HR960272A patent/HRP960272B1/xx not_active IP Right Cessation
- 1996-06-06 EG EG50996A patent/EG25227A/xx active
1997
- 1997-12-05 NO NO19975700A patent/NO314503B1/no not_active IP Right Cessation
1998
- 1998-12-14 US US09/211,483 patent/US6060475A/en not_active Expired - Lifetime
2000
- 2000-02-15 US US09/504,364 patent/US6258817B1/en not_active Expired - Lifetime
2004
- 2004-07-19 GE GE5624A patent/GEP20053470B/en unknown

Also Published As

Publication number	Publication date
US6060475A (en)	2000-05-09
ES2168487T3 (es)	2002-06-16
AR003132A1 (es)	1998-07-08
HUP9802300A2 (hu)	1999-10-28
DE69617236D1 (de)	2002-01-03
HRP960272A2 (en)	1997-08-31
CZ388797A3 (cs)	1998-03-18
GEP20053470B (en)	2005-02-25
CN1097051C (zh)	2002-12-25
HUP9802300A3 (en)	2002-02-28
PT832082E (pt)	2002-04-29
ATE209200T1 (de)	2001-12-15
PL187897B1 (pl)	2004-10-29
NO314503B1 (no)	2003-03-31
TR199701502T1 (xx)	1998-03-21
DE69617236T2 (de)	2002-07-11
EG25227A (en)	2011-11-17
PL324660A1 (en)	1998-06-08
NO975700D0 (no)	1997-12-05
WO1996040681A1 (en)	1996-12-19
EP0832082A1 (en)	1998-04-01
AU715041B2 (en)	2000-01-13
IL122464A0 (en)	1998-09-15
AU5840396A (en)	1996-12-30
JP3193058B2 (ja)	2001-07-30
SK282338B6 (sk)	2002-01-07
TW340845B (en)	1998-09-21
CN1192739A (zh)	1998-09-09
RU2172738C2 (ru)	2001-08-27
DK0832082T3 (da)	2002-05-21
UA58494C2 (uk)	2003-08-15
BR9608611A (pt)	1999-05-11
EP0832082B1 (en)	2001-11-21
US6258817B1 (en)	2001-07-10
JPH11509175A (ja)	1999-08-17
HK1005801A1 (en)	1999-01-29
MX9709521A (es)	1998-03-31
CA2219742C (en)	2007-01-16
NZ308619A (en)	2000-01-28
IL122464A (en)	2002-05-23
KR19990022327A (ko)	1999-03-25
KR100451523B1 (ko)	2004-12-03
CA2219742A1 (en)	1996-12-19
CZ289387B6 (cs)	2002-01-16
SK168097A3 (en)	1998-05-06
HRP960272B1 (en)	2006-06-30
MY114926A (en)	2003-02-28
US5866568A (en)	1999-02-02

Publication	Publication Date	Title
DK0832082T3 (da)	2002-05-21	N-heteroaryl-pyridinsulfonamidderivater og deres anvendelse som endotelinantagonister
NO972983D0 (no)	1997-06-26	Sulfonamider og deres anvendelse
DK0832061T3 (da)	2001-11-19	Benzamidderivater og anvendelse deraf som vasopressin-antagonister
NO943190L (no)	1995-03-01	Sulfonamid-endothelin-antagonister
DK0906292T3 (da)	2003-10-27	Triazolylmercaptider og deres anvendelse som mikrobicider
ATE284385T1 (de)	2004-12-15	Sulfonamidderivate
NO991388D0 (no)	1999-03-22	Sulfonamider og derivater derav som modulerer endothelin aktiviteten
DK0811007T3 (da)	2006-02-06	Pyrazol-4-yl-benzoylderivater og deres anvendelse som herbicider
NO982802D0 (no)	1998-06-18	Nye 5-amino-3-cyano-4-etylsulfinyl-1-fenyl-pyrazol-forbindelser og deres anvendelse som pesticider
NO993658D0 (no)	1999-07-28	Sulfonylurea-derivater
DK0958292T3 (da)	2007-05-07	4-3(3-heterocyclyl-1-benzoyl)pyrazoler og deres anvendelse som herbicider
DK0871656T3 (da)	2003-01-27	Dolastatinderivater, deres fremstilling og anvendelse
DK1019358T4 (da)	2008-01-14	3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO971811D0 (no)	1997-04-18	Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler
NO981522D0 (no)	1998-04-03	Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister
NO984761D0 (no)	1998-10-12	Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO995513L (no)	2000-01-12	N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
NO994510D0 (no)	1999-09-17	Substituerte isokinolin-derivater og deres anvendelse som antikonvulsanter
DK0839146T3 (da)	2000-11-20	Piperazinderivater og deres anvendelse som 5-HT1A-antagonister
NO985891D0 (no)	1998-12-16	Substituerte benzamid-derivater og deres anvendelse som antikonvulsjonsmidler
DK0764157T3 (da)	2002-04-22	Benzopyraner og deres anvendelse som terapeutiske midler
NO951418D0 (no)	1995-04-11	Peptidderivater, deres fremstilling og anvendelse som terapeutika
NO20003142L (no)	2000-06-16	Substituerte isokinolin-derivater og anvendelse derav som antikrampemidler
DK0961774T3 (da)	2002-04-02	Pyrazol-4-yl-benzoylderivater og deres anvendelse som herbicider
NO975130L (no)	1998-01-06	<alfa>-(substituerte alkylfenyl)-4-(hydroxydifenylmethyl)-1-piperidinbutanolderivater, deres fremstilling og deres anvendelse som antihistaminer, anti-allergimidler og bronchodilatorer

Legal Events

Date	Code	Title	Description
2013-02-04	MM1K	Lapsed by not paying the annual fees